Novaliq

Novaliq is a private pharmaceutical company committed to develop transformational ocular therapies. Novaliq has successfully developed the new drug category of water-free topical eye therapies called EyeSol®. This unique and versatile water-free technology is poised to transform established treatments. EyeSol® products are ocular surface beneficial, micro-dosed and non-preserved. As a fully integrated, partially virtual biopharmaceutical company Novaliq continues to revolutionize ocular treatments to realize the full potential of eye care treatments for the benefit of patients in diseases with high unmet needs.